In drug discovery trials, the potential for a molecule to do harm to an organism must be known accurately. Understanding how a substance under investigation behaves once in the body informs the design ...
BUFFALO, N.Y. — When you pop a prescription pill into your mouth, you trust it to address the issue it was meant to fix. But what really happens? How is your body processing the drugs and what happens ...
When you pop a prescription pill into your mouth, you trust it to address the issue it was meant to fix. But what really happens? How is your body processing the drugs and what happens if the dosage ...
The brain is the most advanced organ with various complex structural and functional microregions. It is often challenging to understand what and where the molecular events would occur for a given drug ...
Triptolide is a highly bioactive diterpenoid epoxide derived from Tripterygium wilfordii, notable for its potent antitumour properties across a range of solid and haematological malignancies. Its ...
The US Food and Drug Administration (FDA) has published a draft guidance on how to design trials and analyze data from ...
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer This longitudinal study linked pharmacokinetic assays collected ...
Phase Ib study of BGJ398 in combination with BYL719 in patients (pts) with select advanced solid tumors. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results